These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1071 related articles for article (PubMed ID: 232892)

  • 1. Isolation and characterization of a variant of B16-mouse melanoma resistant to MSH growth inhibition.
    Niles RM; Logue MP
    J Supramol Struct; 1979; 11(2):251-8. PubMed ID: 232892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of melanogenesis in mouse melanoma cells of varying metastatic potential.
    Niles RM; Makarski JS
    J Natl Cancer Inst; 1978 Aug; 61(2):523-6. PubMed ID: 210294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity, binding, and metabolic fate of Ac-[Nle4, D-Phe7]alpha-MSH4-11NH2 with the F1 variant of B16 melanoma cells.
    Panasci LC; McQuillan A; Kaufman M
    J Cell Physiol; 1987 Jul; 132(1):97-103. PubMed ID: 3110178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C.
    Park HY; Russakovsky V; Ao Y; Fernandez E; Gilchrest BA
    Exp Cell Res; 1996 Aug; 227(1):70-9. PubMed ID: 8806453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decay of hormone responsiveness in mouse melanoma cells in culture as a function of cell density.
    Fuller BB; Lebowitz J
    J Cell Physiol; 1980 May; 103(2):279-87. PubMed ID: 6254996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Melanocyte-stimulating hormone binding and biological activity in a human melanoma cell line.
    Legros F; Coel J; Doyen A; Hanson P; Van Tieghem N; Vercammen-Grandjean A; Fruhling J; Lejeune FJ
    Cancer Res; 1981 Apr; 41(4):1539-44. PubMed ID: 6260342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function.
    Swope VB; Abdel-Malek ZA; Sauder DN; Nordlund JJ
    J Immunol; 1989 Mar; 142(6):1943-9. PubMed ID: 2466081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of adenosine 3',5'-cyclic monophosphate in the density-dependent regulation of growth and tyrosinase activity of B-16 melanoma cells.
    Wade DR; Burkart ME
    J Cell Physiol; 1978 Mar; 94(3):265-73. PubMed ID: 202603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal activation of adenylate cyclase in mouse melanoma metastatic variants.
    Niles RM; Makarski JS
    J Cell Physiol; 1978 Sep; 96(3):355-9. PubMed ID: 209054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B16 mouse melanoma cells selected for resistance to cyclic AMP-mediated growth inhibition are cross-resistant to retinoic acid-induced growth inhibition.
    Niles RM; Loewy B
    J Cell Physiol; 1991 Apr; 147(1):176-81. PubMed ID: 1645360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of cAMP-dependent protein kinase is required for optimal alpha-melanocyte-stimulating hormone-induced pigmentation.
    Ao Y; Park HY; Olaizola-Horn S; Gilchrest BA
    Exp Cell Res; 1998 Oct; 244(1):117-24. PubMed ID: 9770355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes.
    Martínez-Esparza M; Solano F; García-Borrón JC
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):991-1000. PubMed ID: 10644003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of adenosine 3',5'-monophosphate in the transformation of Cloudman mouse melanoma cells.
    Lincoln TM; Vaughan GL
    J Cell Physiol; 1975 Dec; 86(3 Pt 1):543-51. PubMed ID: 172519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
    Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
    Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C down-regulation, and not transient activation, correlates with melanocyte growth.
    Brooks G; Wilson RE; Dooley TP; Goss MW; Hart IR
    Cancer Res; 1991 Jun; 51(12):3281-8. PubMed ID: 2040003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenylate cyclase activity in homogenates of human melanoma cells. Effect of alpha-MSH and isoprenaline.
    Karg E; Johansson LH; Hindemith-Augustsson A; Rosengren E; Rorsman H
    Acta Derm Venereol; 1989; 69(4):288-91. PubMed ID: 2568044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of melanotropins on mouse melanoma cell growth in vitro.
    Abdel Malek ZA; Hadley ME; Bregman MD; Meyskens FL; Hruby VJ
    J Natl Cancer Inst; 1986 May; 76(5):857-63. PubMed ID: 3009949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple mechanisms of growth inhibition by cyclic AMP derivatives in rat GH1 pituitary cells: isolation of an adenylate cyclase-deficient variant.
    Martin TF; Ronning SA
    J Cell Physiol; 1981 Nov; 109(2):289-97. PubMed ID: 6271795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine responsiveness in human melanocytes and melanoma cells in culture.
    Fuller BB; Meyskens FL
    J Natl Cancer Inst; 1981 May; 66(5):799-802. PubMed ID: 6262556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma cells resistant to inhibition of growth by melanocyte stimulating hormone.
    Pawelek J; Sansone M; Koch N; Christie G; Halaban R; Hendee J; Lerner AB; Varga JM
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):951-5. PubMed ID: 165495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.